Characteristics of intracerebral hemorrhage associated with dual antiplatelet treatment [0.03%]
双重抗血小板治疗相关的自发性脑出血的临床特点分析
Andrea Morotti,Jawed Nawabi,Qi Li et al.
Andrea Morotti et al.
Background: Antiplatelet treatment is associated with hematoma expansion (HE) and poor outcome in intracerebral hemorrhage (ICH). We aimed to describe the characteristics of ICH associated with dual antiplatelet treatment...
Multicenter Study
Journal of neurology. 2025 Aug 30;272(9):601. DOI:10.1007/s00415-025-13339-y 2025
Comparing caloric and self-experienced dizziness symptoms: diagnostic value and implications in functional dizziness [0.03%]
从诊断价值和功能性眩晕的含义方面比较卡里奇和自我体验到的头晕症状
Jörn K Pomper,Saskia Rabe,Uwe Ilg et al.
Jörn K Pomper et al.
Background: The diagnostic value of dizziness symptom quality is limited by variability in patient self-reports. Comparing it to the experience during standardized caloric stimulation could help control for individual dif...
Comparative Study
Journal of neurology. 2025 Aug 30;272(9):600. DOI:10.1007/s00415-025-13334-3 2025
Juan Carlos García-Moncó,Jorge L Benach
Juan Carlos García-Moncó
Diseases transmitted by ticks have been increasing in frequency and distribution, partly due to climate change. In the last decades, new tick-borne pathogens have been discovered that cause prominent neurologic disease. In this review, the ...
Quality of life measures in Parkinson's disease: a systematic literature review of patient-reported outcomes measures (PROMs) and their psychometric properties [0.03%]
帕金森病生活质量测量：系统性文献综述及患者报告结果量表(PROMs)的计量学性质
Alberto de la Cuadra-Grande,Javier Rejas,Miguel Ángel Casado et al.
Alberto de la Cuadra-Grande et al.
Background: Quality-of-life (QoL) measures are key for monitoring health of patients with Parkinson's disease (PD). Objective: This sys...
Evaluating 18F-Florzolotau tau PET for Alzheimer's disease diagnosis with 18F-Flortaucipir as reference [0.03%]
使用18F-Flortaucipir作为参考评估18F-Florzolotautau-PET在阿尔茨海默病诊断中的应用价值
Qi Zhang,Jiaying Lu,Luyao Wang et al.
Qi Zhang et al.
Introduction: Tau protein aggregation is a hallmark of Alzheimer's disease (AD) pathology. Semi-quantitative analysis using regions of interest (ROIs)-based standardized uptake value ratios (SUVRs) serves as a major Tau p...
Fragile X-associated tremor/ataxia syndrome: a case report with atypical spinal cord atrophy and altered somatosensory evoked potentials [0.03%]
染色体脆性X染色体关联震颤/共济失调综合征1例报告及磁共振分析
Giulia Rugarli,Giorgio Maria Agazzi,Roberto Santangelo et al.
Giulia Rugarli et al.
A population-based study of severe, less common comorbidities in Duchenne muscular dystrophy [0.03%]
杜氏肌营养不良严重罕见并发症的流行病学研究
Lisa Wahlgren,Sara Nordström,Már Tulinius et al.
Lisa Wahlgren et al.
Background: Since the increasing longevity and the advent of new therapeutic modalities in Duchenne muscular dystrophy (DMD), comprehensive clinical surveillance is of paramount importance. Our study aimed to examine the ...
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates [0.03%]
短暂性全面性遗忘症患者的头晕和空间定向障碍的临床和前庭相关因素
Ileok Jung,Jin-Man Jung,Moon-Ho Park et al.
Ileok Jung et al.
Objective: To determine the prevalence and clinical significance of dizziness and spatial disorientation in patients with transient global amnesia (TGA), and to examine their relationships with vestibular function and ima...
Not for everyone: examining predictors of cognitive rehabilitation success in multiple sclerosis [0.03%]
并非适合所有人：探究多发性硬化认知康复成功的预测因素
Anne Kever,Nayeon Kang,Cecilia Meza et al.
Anne Kever et al.
Cerebrospinal fluid levels of chitinase 3-like 1 and interleukin-6 can predict response to platform therapies in relapsing multiple sclerosis [0.03%]
脑脊液中半乳糖凝集素家族成员CHI3L1和IL-6可以预测复发型多发性硬化平台治疗的疗效
Guillaume Mathey,Jonathan Epstein,Tom Alix et al.
Guillaume Mathey et al.
Background: Platform therapies, such as dimethylfumarate, teriflunomide, and interferons beta, are insufficient to control relapsing-remitting multiple sclerosis in many patients. Having biomarkers available to stratify p...